Vazegepant hydrochloride
Modify Date: 2024-01-05 19:15:45
Vazegepant hydrochloride structure
|
Common Name | Vazegepant hydrochloride | ||
|---|---|---|---|---|
| CAS Number | 1414976-20-7 | Molecular Weight | 675.26 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C36H47ClN8O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Vazegepant hydrochlorideVazegepant (BHV-3500) hydrochloride is a highly affinity CGRP receptor antagonist (hCGRP Ki= 0.023 nM). Vazegepant hydrochloride is the first intranasal gepant for migraine. Vazegepant hydrochloride may be helpful in effective management of COVID-19 associated pulmonary inflammation[1][2][3]. |
| Name | Vazegepant hydrochloride |
|---|
| Description | Vazegepant (BHV-3500) hydrochloride is a highly affinity CGRP receptor antagonist (hCGRP Ki= 0.023 nM). Vazegepant hydrochloride is the first intranasal gepant for migraine. Vazegepant hydrochloride may be helpful in effective management of COVID-19 associated pulmonary inflammation[1][2][3]. |
|---|---|
| Related Catalog | |
| Target |
Ki: 0.023 nM (hCGRP)[3] |
| References |
| Molecular Formula | C36H47ClN8O3 |
|---|---|
| Molecular Weight | 675.26 |